Pancreatic Cancer Research

ResearcherMayo ClinicNo recent work listed

Michael B. Farnell

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5107413738. Sources: OpenAlex.

Their work

Papers
13 (first author 2, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
36
Papers, trials and grants by year

2011: 2 papers · 2012: 1 paper · 2013: none · 2014: 2 papers · 2015: 1 paper · 2016: 2 papers · 2017: 3 papers · 2018: 1 paper · 2019: 1 paper

Papers 13

  1. Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention-to-treat analysis. Co-author DOI 10.1002/jso.25681↗
  2. Decreased Skeletal Muscle Volume Is a Predictive Factor for Poorer Survival in Patients Undergoing Surgical Resection for Pancreatic Ductal Adenocarcinoma. First author DOI 10.1007/s11605-018-3695-z↗
  3. Endoscopic Ultrasound Fine-Needle Aspiration Diagnosis of Synchronous Primary Pancreatic Adenocarcinoma and Effects on Staging and Resectability. Co-author DOI 10.1016/j.cgh.2016.08.009↗
  4. EUS-guided fine-needle injection of gemcitabine for locally advanced and metastatic pancreatic cancer. Co-author DOI 10.1016/j.gie.2016.11.014↗
  5. Type of Resection (Whipple vs. Distal) Does Not Affect the National Failure to Provide Post-resection Adjuvant Chemotherapy in Localized Pancreatic Cancer. Co-author DOI 10.1245/s10434-016-5762-6↗
  6. Carbohydrate Antigen 19-9 Elevation in Anatomically Resectable, Early Stage Pancreatic Cancer Is Independently Associated with Decreased Overall Survival and a… Co-author DOI 10.1016/j.jamcollsurg.2016.02.009↗
  7. Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chem… Last author DOI 10.1016/j.surg.2016.06.010↗
  8. Laparoscopic Pancreaticoduodenectomy: Is It an Effective Procedure for Pancreatic Ductal Adenocarcinoma? Last author DOI 10.1016/j.yasu.2015.03.003↗
  9. Total laparoscopic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: oncologic advantages over open approaches? First author DOI 10.1097/sla.0000000000000937↗
  10. Clinical characteristics and overall survival in patients with anaplastic pancreatic cancer. Co-author DOI 10.1177/000313481408000218↗
  11. Number of lymph nodes evaluated: prognostic value in pancreatic adenocarcinoma. Co-author DOI 10.1007/s11605-012-1853-2↗
  12. Patterns of pancreatic resection differ between patients with familial and sporadic pancreatic cancer. Co-author DOI 10.1007/s11605-011-1417-x↗
  13. Survival after resection for invasive intraductal papillary mucinous neoplasm and for pancreatic adenocarcinoma: a multi-institutional comparison according to … Co-author DOI 10.1016/j.jamcollsurg.2011.04.003↗

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michael L. Kendrick · 11 shared papers, 2011–2019 · strength 0.66
  2. Mark Joseph Truty · 7 shared papers, 2014–2019 · strength 0.46
  3. Suresh T. Chari · 4 shared papers, 2017–2019 · strength 0.29
  4. Naoki Takahashi · 3 shared papers, 2017–2019 · strength 0.23
  5. Christopher R. Shubert · 3 shared papers, 2016–2017 · strength 0.18
  6. John R. Bergquist · 3 shared papers, 2016–2017 · strength 0.18
  7. Motokazu Sugimoto · 2 shared papers, 2018–2019 · strength 0.17
  8. Gloria M. Petersen · 3 shared papers, 2011–2018 · strength 0.16
  9. Ferga C. Gleeson · 2 shared papers, 2017 · strength 0.12
  10. Michael J. Levy · 2 shared papers, 2017 · strength 0.12
  11. Florencia G. Que · 3 shared papers, 2011–2014 · strength 0.10
  12. Thomas C. Smyrk · 1 shared paper, 2019 · strength 0.09
  13. May C. Tee · 1 shared paper, 2015 · strength 0.08
  14. Kaye M. Reid–Lombardo · 2 shared papers, 2012–2014 · strength 0.08
  15. Michael R. Moynagh · 1 shared paper, 2018 · strength 0.08
  16. Ann L. Oberg · 1 shared paper, 2017 · strength 0.06
  17. Steven R. Alberts · 1 shared paper, 2017 · strength 0.06
  18. Michael G. Haddock · 1 shared paper, 2017 · strength 0.06
  19. Mark D. Topazian · 1 shared paper, 2017 · strength 0.06
  20. Tarun Rustagi · 1 shared paper, 2017 · strength 0.06
  21. Kenneth K. Wang · 1 shared paper, 2017 · strength 0.06
  22. Randall K. Pearson · 1 shared paper, 2017 · strength 0.06
  23. Santhi Swaroop Vege · 1 shared paper, 2017 · strength 0.06
  24. Michael G. Sarr · 2 shared papers, 2011–2012 · strength 0.06
  25. Lizhi Zhang · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.